Page last updated: 2024-10-20

uracil and Pemphigoid, Bullous

uracil has been researched along with Pemphigoid, Bullous in 4 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Pemphigoid, Bullous: A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Hung, CT1
Liu, JS1
Cheng, CY1
Chung, CH1
Chiang, CP1
Chien, WC1
Wang, WM1
Zafar, M1
Shahbaz, M1
Hawley, I1
Rahmani, MJ1
Fania, L1
Salemme, A1
Provini, A1
Pagnanelli, G1
Collina, MC1
Abeni, D1
Didona, B1
Di Zenzo, G1
Mazzanti, C1
Takata, Y1
Higashiyama, M1
Tanaka, A1
Suzuki, S1
Miura, H1
Fujiwara, S1

Other Studies

4 other studies available for uracil and Pemphigoid, Bullous

ArticleYear
Increased risk of bullous pemphigoid in dipeptidyl peptidase 4 inhibitors: A nationwide, population-based, cohort study in Taiwan.
    The Journal of dermatology, 2020, Volume: 47, Issue:3

    Topics: Adamantane; Adult; Age Factors; Aged; Case-Control Studies; Databases, Factual; Diabetes Mellitus, T

2020
Alogliptin-induced bullous pemphigoid.
    British journal of hospital medicine (London, England : 2005), 2020, Jul-02, Volume: 81, Issue:7

    Topics: Aged; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Pemphigoid, Bullous; Piperidin

2020
Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors.
    Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3

    Topics: Adamantane; Aged; Aged, 80 and over; Autoantibodies; Autoantigens; Collagen Type XVII; Dipeptidyl-Pe

2018
Alogliptin-induced bullous pemphigoid associated with HLA-DQB1*03:01: a case report.
    International journal of dermatology, 2019, Volume: 58, Issue:7

    Topics: Aged; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Female; HLA-DQ beta-Chains; Humans; Pem

2019